MEDINDIA
English
हिन्दी
Español
français
中文
Email
Acetyldigitoxin
Acetyldigitoxin may decrease the cardiotoxic activities of Molgramostim.
Ancestim
The risk or severity of cytotoxicity can be increased when Ancestim is combined with Molgramostim.
Bevacizumab
Bevacizumab may increase the cardiotoxic activities of Molgramostim.
Bevacizumab-Awwb
Bevacizumab may increase the cardiotoxic activities of Molgramostim.
Cabazitaxel
The risk or severity of adverse effects can be increased when Cabazitaxel is combined with Molgramostim.
Cyclophosphamide
Cyclophosphamide may increase the cardiotoxic activities of Molgramostim.
Cyclophosphamide Anhydrous
Cyclophosphamide may increase the cardiotoxic activities of Molgramostim.
Deslanoside
Deslanoside may decrease the cardiotoxic activities of Molgramostim.
Digitoxin
Digitoxin may decrease the cardiotoxic activities of Molgramostim.
Digoxin
Digoxin may decrease the cardiotoxic activities of Molgramostim.
Docetaxel
The risk or severity of adverse effects can be increased when Docetaxel is combined with Molgramostim.
DOCETAXEL ANHYDROUS
The risk or severity of adverse effects can be increased when Docetaxel is combined with Molgramostim.
Ouabain
Ouabain may decrease the cardiotoxic activities of Molgramostim.
Ovine Digoxin Immune Fab
Digoxin Immune Fab (Ovine) may decrease the cardiotoxic activities of Molgramostim.
Paclitaxel
The risk or severity of adverse effects can be increased when Paclitaxel is combined with Molgramostim.
Proscillaridin
Proscillaridin may decrease the cardiotoxic activities of Molgramostim.
Trastuzumab
Trastuzumab may increase the cardiotoxic activities of Molgramostim.
